Home › DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac
 

Keywords :   


DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac

2014-10-01 11:13:37| Biotech - Topix.net

DanDrit Biotech A/S , the subsidiary of DanDrit Biotech USA, Inc. , a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST - National Institute for Cancer Research known as the San Martino Hospital of Genoa. Dr. Alberto Sobrero, the Head of the Medical Oncology Unit at the San Martino Hospital is principal investigator of the randomized multicenter study.

Tags: agreement signs clinical trials

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Rates low for too long, says ex-Bank of England boss
29.09Weekly Recap: Freudenberg Expands Coated Textiles Business, Trade Associations to Explore Alliance
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Forecast Advisory Number 9
29.09Summary for Tropical Storm Joyce (AT1/AL112024)
29.09Hurricane Isaac Graphics
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Oasis ticket seller and promoter bosses get 14.8m
More »